Table 2 Sex-specific vaccine efficacy.

cDNA-CPFhW/pcDNA3.1^a

Rat

100%

74%

[156]

CPFhW inclusion bodies^b

Cattle

None

54%

[157]

CPFhW inclusion bodies^b

Sheep

26%

None

[157]

cDNA-FhPGK/pCMV^b

Rat

None

67%

[158]

FhPGK^a

Rat

55%

69%

[158]

cDNA-FhPCW/pCMV^a

Rat

None

19%

[159]

cDNA-FhPGK/pCMV^a

Rat

None

48%

[129]

Fh-CL3-1^a

Rat

47%

None

[160, 161]

Fh-CL3-2^a

Rat

63%

21%

[160, 161]

CPFhW^c

Sheep

55%

20%

[162]

CPFhW^c

Cattle

46%

68%

[162]